NCCTG phase II trial of bevacizumab, gemcitabine, oxaliplatin in patients with metastatic pancreatic adenocarcinoma.

被引：0
|
作者：
Kim, G. P.
Oberg, A.
Kabat, B.
Sing, A.
Hedrick, E.
Campbell, D.
Alberts, S.
机构：
[1] N Cent Canc Treatment Grp, Rochester, MN USA
[2] Genentech Inc, San Francisco, CA 94080 USA
[3] SanofiAventis, Bridgewater, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4113
引用
收藏
页码：206S / 206S
页数：1
相关论文
共 50 条
  • [41] Randomized phase II trial of panitumumab (P), erlotinib (E), and gemcitabine (G) versus erlotinib-gemcitabine in patients with untreated, metastatic pancreatic adenocarcinoma
    Kim, G. P.
    Foster, N. R.
    Salim, M.
    Flynn, P. J.
    Moore, D. F., Jr.
    Zon, R.
    Mowat, R. B.
    McCullough, A.
    Meyers, J. P.
    Alberts, S. R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [42] Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma
    Zhu, AX
    Blaszkowsky, LS
    Ryan, DP
    Clark, JW
    Muzikansky, A
    Horgan, K
    Sheehan, S
    Hale, KE
    Enzinger, PC
    Bhargava, P
    Stuart, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (12) : 1898 - 1903
  • [43] A phase II trial of gemcitabine and celecoxib for metastatic pancreatic cancer.
    Xiong, HQ
    Hess, KR
    Kayaleh, OR
    Goodwin, JW
    Banerjee, T
    Sinclair, SS
    Fisch, MJ
    Wolff, RA
    Abbruzzese, JL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 351S - 351S
  • [44] Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study
    Roberto Petrioli
    Giandomenico Roviello
    Anna Ida Fiaschi
    Letizia Laera
    Daniele Marrelli
    Franco Roviello
    Edoardo Francini
    [J]. Cancer Chemotherapy and Pharmacology, 2015, 75 : 683 - 690
  • [45] Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study
    Petrioli, Roberto
    Roviello, Giandomenico
    Fiaschi, Anna Ida
    Laera, Letizia
    Marrelli, Daniele
    Roviello, Franco
    Francini, Edoardo
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (04) : 683 - 690
  • [46] A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinoma
    Ko, Andrew H.
    Youssoufian, Hagop
    Gurtler, Jayne
    Dicke, Karel
    Kayaleh, Omar
    Lenz, Heinz-Josef
    Keaton, Mark
    Katz, Terry
    Ballal, Shaila
    Rowinsky, Eric K.
    [J]. INVESTIGATIONAL NEW DRUGS, 2012, 30 (04) : 1597 - 1606
  • [47] A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinoma
    Andrew H. Ko
    Hagop Youssoufian
    Jayne Gurtler
    Karel Dicke
    Omar Kayaleh
    Heinz-Josef Lenz
    Mark Keaton
    Terry Katz
    Shaila Ballal
    Eric K. Rowinsky
    [J]. Investigational New Drugs, 2012, 30 : 1597 - 1606
  • [48] Pimasertib plus gemcitabine in metastatic pancreatic adenocarcinoma: Results of a safety run-in part of a phase II trial
    Verslype, Chris
    Hammel, Pascal
    Hidalgo, Manuel
    Macarulla, Teresa
    Garcia-Carbonero, Rocio
    Andre, Thierry
    Van den Eynde, Marc
    Saez, Berta Laquente
    Milella, Michele
    Raymond, Eric
    Faivre, Thea
    Milner, Alvin
    Tarabaric, Dolores
    Locatelli, Giuseppe
    von Richter, Oliver
    Laffranchi, Bernard
    Van Cutsem, Eric
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [49] A phase Ib/IIa study of combination therapy with gemcitabine and Atu027 in patients with locally advanced or metastatic pancreatic adenocarcinoma.
    Schultheis, Beate
    Strumberg, Dirk
    Kuhlmann, Jan
    Wolf, Martin
    Link, Karin
    Seufferlein, Thomas
    Kaufmann, Joerg
    Gebhardt, Frank
    Bruyniks, Nico
    Pelzer, Uwe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [50] A Single-Arm, Nonrandomized Phase II Trial of Neoadjuvant Gemcitabine and Oxaliplatin in Patients With Resectable Pancreas Adenocarcinoma
    O'Reilly, Eileen M.
    Perelshteyn, Anna
    Jarnagin, William R.
    Schattner, Mark
    Gerdes, Hans
    Capanu, Marinela
    Tang, Laura H.
    LaValle, Joseph
    Winston, Corinne
    DeMatteo, Ronald P.
    D'Angelica, Michael
    Kurtz, Robert C.
    Abou-Alfa, Ghassan K.
    Klimstra, David S.
    Lowery, Maeve A.
    Brennan, Murray F.
    Coit, Daniel G.
    Reidy, Diane L.
    Kingham, T. Peter
    Allen, Peter J.
    [J]. ANNALS OF SURGERY, 2014, 260 (01) : 142 - 148
12345